Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Aksamit

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Respirology (Carlton, Vic.)|June 22, 2019
Paediatric and adult bronchiectasis: Specific management with coexisting asthma, COPD, rheumatological disease and inflammatory bowel diseaseMarco Maglione, Timothy Aksamit, Francesca Santamaria
Chest|October 7, 2018
Bronchiectasis and Chronic Airway Disease: It Is Not Just About Asthma and COPDMiguel Angel Martinez-Garcia, Eva Polverino, Timothy Aksamit
Journal of Thoracic Disease|October 29, 2025
Use of long-term inhaled antibiotics and macrolides: insights from the four global bronchiectasis registriesTimothy Aksamit, Wei-Jie Guan, Miguel-Angel Martinez-Garcia
BMC Pulmonary Medicine|December 3, 2022
Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settingsTimothy Aksamit, Jasmanda Wu, Mariam Hassan, et al.
The European Respiratory Journal|June 30, 2022
World Bronchiectasis Day 2022James D Chalmers, Timothy Aksamit, Stefano Aliberti, et al.
Minnesota Medicine|March 3, 2010
An innovative model for tuberculosis control: an academic medical center-public health department partnershipPrathibha Varkey, Samar Harris, Larry Edmonson, et al.
Medicina (Kaunas, Lithuania)|August 26, 2022
Artificial Intelligence-Augmented Propensity Score, Cost Effectiveness and Computational Ethical Analysis of Cardiac Arrest and Active Cancer with Novel Mortality Predictive ScoreDominique J Monlezun, Oleg Sinyavskiy, Nathaniel Peters, et al.
Respiratory Medicine|August 6, 2016
Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasisRobert Wilson, Timothy Aksamit, Stefano Aliberti, et al.
Contemporary Clinical Trials|May 13, 2017
The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasisTimothy Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, et al.
The European Respiratory Journal|January 27, 2018
RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasisAnthony De Soyza, Timothy Aksamit, Tiemo-Joerg Bandel, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Respirology (Carlton, Vic.)|June 22, 2019
Paediatric and adult bronchiectasis: Specific management with coexisting asthma, COPD, rheumatological disease and inflammatory bowel diseaseMarco Maglione, Timothy Aksamit, Francesca Santamaria
Chest|October 7, 2018
Bronchiectasis and Chronic Airway Disease: It Is Not Just About Asthma and COPDMiguel Angel Martinez-Garcia, Eva Polverino, Timothy Aksamit
Journal of Thoracic Disease|October 29, 2025
Use of long-term inhaled antibiotics and macrolides: insights from the four global bronchiectasis registriesTimothy Aksamit, Wei-Jie Guan, Miguel-Angel Martinez-Garcia
BMC Pulmonary Medicine|December 3, 2022
Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settingsTimothy Aksamit, Jasmanda Wu, Mariam Hassan, et al.
The European Respiratory Journal|June 30, 2022
World Bronchiectasis Day 2022James D Chalmers, Timothy Aksamit, Stefano Aliberti, et al.
Minnesota Medicine|March 3, 2010
An innovative model for tuberculosis control: an academic medical center-public health department partnershipPrathibha Varkey, Samar Harris, Larry Edmonson, et al.
Medicina (Kaunas, Lithuania)|August 26, 2022
Artificial Intelligence-Augmented Propensity Score, Cost Effectiveness and Computational Ethical Analysis of Cardiac Arrest and Active Cancer with Novel Mortality Predictive ScoreDominique J Monlezun, Oleg Sinyavskiy, Nathaniel Peters, et al.
Respiratory Medicine|August 6, 2016
Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasisRobert Wilson, Timothy Aksamit, Stefano Aliberti, et al.
Contemporary Clinical Trials|May 13, 2017
The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasisTimothy Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, et al.
The European Respiratory Journal|January 27, 2018
RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasisAnthony De Soyza, Timothy Aksamit, Tiemo-Joerg Bandel, et al.
Pageof 3